Future Trends in Next Generation Sequencing Technologies

Published: April 2025

Over the years, the next generation sequencing market has witnessed substantial automation in sequencing platforms and emerged as one of the markedly growing domains of the pharmaceutical industry. Continuous automation and extensive research efforts in this sector have led to the utilization of NGS technologies for varied applications including targeted and personalized therapies.

Automation in next generation sequencing (or massively parallel sequencing) has largely transformed the field of genomics and bioinformatics by allowing high-throughput genome sequencing. This groundbreaking technology can sequence millions of DNA or RNA sequences in a time and cost-efficient manner. Further, the impact of automation on the growth of NGS market has been nothing short of transformative, particularly by expanding horizons of NGS technologies for varied purposes (including diagnostic, forensic, environmental and microbial studies).

Presently, technological advancements in the next generation sequencing market majorly focus on streamlining library preparation, high-throughput sequencing and data analysis in order to produce more accurate and reproducible outcomes. Further, researchers are integrating nanotechnology and artificial intelligence in NGS technologies to ensure reliability and robustness of the platforms. Therefore, the ongoing research and development efforts for automation in this domain hold promises for revolutionizing the field of genomics and molecular biology in the future.

With the growing demand of next generation sequencing and ongoing advancements in the NGS technologies (focused on miniaturization, nanotechnology, targeted sequencing and multiplexing), the next generation sequencing market is likely to grow, in the foreseen future.

Roots Analysis has conducted an exhaustive study on Next Generation Sequencing Market featuring the current market landscape and future opportunity for the companies engaged in offering next generation sequencing services and technologies, over a span of 10 years. In this article, we have highlighted future trends in next generation sequencing technologies, including automation and its impact on NGS technology that are likely to shape the evolution of the market.

Add Image alt text here

Want to explore the future trends in next generation sequencing technologies and its impact on market growth??

Access Detailed Insights

Notable Future Trends in Next Generation Sequencing Technologies that are Likely to Shape the NGS Market

1. Nanopore Sequencing: A Roadmap to Nanoscale Sequencing

Automated nanopore sequencing has revolutionized the next-generation sequencing domain, as it threads single DNA or RNA strands through a nano-membrane in order to generate a unique pattern of the genome sequences. Nanopore sequencing has the ability to produce long base pair reads per run and perform automated real-time sequencing directly on DNA or RNA, thus being largely applied to transcriptomics and pathogen detection studies.

It is worth mentioning that, in February 2025, Roche developed its first breakthrough sequencing by expansion (SBX) technology (a second generation and improved nanopore sequencing method).

2. Automated Library Preparation: Spearheading the Technological Revolution of NGS

Automated library preparation models in NGS technologies are rapidly expediting the NGS market growth by significantly improving accessibility, cost-effectiveness and efficiency as compared to the traditional approaches. Automated library models have the ability to produce large sample volumes simultaneously in order to increase throughput and reduce turnaround times, enabling efficient data analysis.

Moreover, in conjunction with the reduced human errors, it has enhanced the reproducibility of NGS outcomes. It is worth mentioning that these automated systems have also strengthened the foundation for NGS applicability by contributing to the heightened adoption of NGS technologies. Examples of automated library preparation include SureSelect^XT Reagent Kit (Agilent) and Nextera XT DNA Library Preparation Kit (Illumina).

Request Sample Pages

3. Automated High-throughput Sequencing: Emphasizing High Resolution Analysis

Automated high-throughput sequencing (HTS) has remarkably accelerated the growth of the next-generation sequencing market by reducing both time and cost associated with conventional sequencing systems, making it more potential for the development of novel diagnostic and therapeutic approaches.

Such automation have encouraged large-scale genomic studies and driven innovations in therapeutic areas such as oncology rare and genetic disorders. Further, it is worth noting that Illumina offers a wide range of benchtop NGS sequencers, including NovaSeq 6000 System, a high-throughput sequencing technology.

4. Semi-conductor Sequencing: Enabling Real Time Monitoring / Detection

Semi-conductor sequencing, a breakthrough advancement in the NGS domain, uses semiconductor chips to amplify, sequence and detect genomic data in order to generate highly accurate and efficient results.

Semi-conductor sequencing outstands in conducting real-time, high-throughput analysis, offering high sensitivity, making it ideal for small-scale genomic studies, personalized medicine and disease diagnosis. Further, it is worth mentioning that Thermo Fisher Scientific offers Ion Torrent semiconductor sequencing technology.

5. Systematic Data Analysis: Increased Reproducibility and Quality

The integration of spatial transcriptomics within NGS technologies helps in providing a spatial genetic map of tissues to reveal the location and distribution of a specific transcript. By combining spatial information with gene expression data, spatial transcriptomics uncover the intricate relationships between cells and their microenvironment. This offers novel opportunities for comprehending tissue development, disease pathology and the drug-receptor interactions.

In May 2025, Complete Genomics entered a commercial partnership with Human Cell Atlas (HCA) to offer its Spatio-Temporal Enhanced Resolution Omics sequencing, or Stereo-seq transcriptomic technology.

6. Ongoing Efforts for the Integration of Artificial Intelligence in NGS Technologies: Impact of AI on Next-Generation Sequencing Data Analysis

Integration of artificial intelligence (AI) with NGS technologies has emerged as a powerful tool by revolutionizing data analysis and interpretation. AI algorithms are used for various purposes including data collection, analysis and interpretation.

This eventually automates and improves the accuracy and efficiency of NGS workflows in the development of personalized medicine and forensic studies. In Jan 2025, Illumina announced a strategic partnership with Nvidia to apply genomics and AI technologies to analyze and interpret multi-omic data in drug discovery, clinical research and overall human health.

Conclusion

The future trends in the next generation sequencing technologies are in accordance with the emerging move towards rapid, accurate and cost-effective genome sequencing. Over the years, NGS platforms have exemplified noteworthy potential in various fields such as disease diagnosis, forensic sciences, environmental and microbial studies.

The increasing perception and heightened adoption of NGS technologies across the globe has further expanded the utility of such techniques. Moreover, the emerging innovations and automated advancements within these platforms has driven the demand for NGS-based targeted and personalized therapies. Consequently, several NGS platforms have revolutionized in the recent years with an intent of accurate and time-efficient genome sequencing.

It is worth mentioning that the integration of cutting-edge and automated technologies, such as automated lab preparation models, artificial intelligence and nanotechnology, has not only expedited the adoption of next generation sequencing but also widened their potential to be applied to unprecedented sectors. These automations are momentous, as they form a foundation for more reproducible and precise sequencing, addressing the need to foster disease diagnosis, prevention and treatment.

Moreover, continuous R&D efforts are essential to improve the speed and accuracy of these technologies, while also exploring their applicability in a wide range of sectors. Such continuous revolution in this domain serves as a foundation for significant reduction in the setbacks associated with conventional methods, ultimately improving the sequencing procedures. Taking into consideration the rise in ongoing efforts for innovating and automating NGS technologies, the next generation sequencing market is anticipated to grow substantially in the foreseen future.

Browse our full report on Next Generation Sequencing Market:

https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html#overview

Sources